Comprehensive Assessment of Left Ventricular Mass, Its Derived Indices, and Relative Wall Thickness in Ischemic Heart

Qiang Zhang1, Hui Cai2, Jiahao Pan1

  • 1Department of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Nantong, China.

Cardiology
|March 13, 2026
PubMed

Insights

Left ventricular mass index (LVMI) and relative wall thickness (RWT) are key indicators for predicting adverse events in ischemic heart disease (IHD). Their assessment aids in risk stratification and personalized treatment strategies for IHD patients.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Pathophysiology

Background:

  • Ischemic heart disease (IHD) is a major cause of cardiovascular death globally.
  • Left ventricular (LV) remodeling, measured by LV mass index (LVMI) and relative wall thickness (RWT), is critical in IHD progression.
  • LV remodeling links ischemic events to clinical outcomes.

Purpose of the Study:

  • To review the mechanisms, prognostic significance, and clinical impact of LV mass, LVMI, and RWT in IHD.
  • To synthesize current evidence on these echocardiographic parameters in the context of IHD.

Main Methods:

  • A comprehensive narrative synthesis approach was employed.
  • Systematic literature searches were conducted across major biomedical databases.
  • Relevant studies on LV remodeling in IHD were analyzed.

Main Results:

  • LVMI and RWT are strong, independent predictors of adverse cardiovascular events in IHD.
  • Concentric hypertrophy (high LVMI and RWT) presents the highest risk across imaging methods.
  • These metrics offer prognostic value beyond traditional risk factors and indicate treatment response.

Conclusions:

  • Integrated assessment of LVMI and RWT is vital for IHD risk stratification and personalized management.
  • Standardized therapeutic targets and surrogate endpoints in clinical trials require further research.
  • Dynamic assessment of LVMI and RWT provides insights into therapeutic efficacy.
Abstract

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
384
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
566
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
611